Tabula Rasa HealthCare (NASDAQ:TRHC) Downgraded by Zacks Investment Research to “Hold”

Share on StockTwits

Zacks Investment Research downgraded shares of Tabula Rasa HealthCare (NASDAQ:TRHC) from a buy rating to a hold rating in a research report sent to investors on Thursday morning, Zacks.com reports.

According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “

A number of other research firms also recently issued reports on TRHC. Stifel Nicolaus raised shares of Tabula Rasa HealthCare from a hold rating to a buy rating and increased their target price for the stock from $50.00 to $75.00 in a research report on Friday, August 30th. BidaskClub downgraded shares of Tabula Rasa HealthCare from a strong-buy rating to a buy rating in a research report on Wednesday, September 4th. Finally, ValuEngine raised shares of Tabula Rasa HealthCare from a buy rating to a strong-buy rating in a research report on Wednesday, September 4th. Three analysts have rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $80.43.

TRHC traded down $0.23 on Thursday, reaching $51.30. 139,666 shares of the company’s stock were exchanged, compared to its average volume of 272,348. The company’s 50 day moving average is $56.56 and its 200-day moving average is $53.58. The company has a market cap of $1.15 billion, a price-to-earnings ratio of 150.88 and a beta of 1.66. Tabula Rasa HealthCare has a twelve month low of $40.86 and a twelve month high of $83.37. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.90 and a current ratio of 1.97.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Thursday, August 8th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.29. The firm had revenue of $76.26 million during the quarter, compared to the consensus estimate of $70.40 million. Tabula Rasa HealthCare had a negative net margin of 7.09% and a positive return on equity of 3.63%. The company’s revenue was up 56.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.20 EPS. Sell-side analysts forecast that Tabula Rasa HealthCare will post -0.15 EPS for the current year.

In other Tabula Rasa HealthCare news, President Orsula V. Knowlton sold 8,000 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $54.85, for a total value of $438,800.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gordon Tunstall sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 14th. The shares were sold at an average price of $62.64, for a total transaction of $62,640.00. The disclosure for this sale can be found here. Insiders sold 77,000 shares of company stock valued at $4,482,300 in the last ninety days. 11.80% of the stock is owned by corporate insiders.

A number of large investors have recently modified their holdings of TRHC. Aperio Group LLC acquired a new stake in Tabula Rasa HealthCare in the second quarter valued at approximately $39,000. First Mercantile Trust Co. boosted its stake in shares of Tabula Rasa HealthCare by 20.3% during the 2nd quarter. First Mercantile Trust Co. now owns 1,197 shares of the company’s stock valued at $60,000 after buying an additional 202 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. purchased a new position in shares of Tabula Rasa HealthCare during the 2nd quarter valued at approximately $82,000. Bank of Montreal Can boosted its stake in shares of Tabula Rasa HealthCare by 167.7% during the 2nd quarter. Bank of Montreal Can now owns 2,605 shares of the company’s stock valued at $129,000 after buying an additional 1,632 shares during the last quarter. Finally, Neuburgh Advisers LLC boosted its stake in shares of Tabula Rasa HealthCare by 18.2% during the 2nd quarter. Neuburgh Advisers LLC now owns 2,704 shares of the company’s stock valued at $135,000 after buying an additional 416 shares during the last quarter. 98.75% of the stock is owned by institutional investors.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

Featured Article: Do back-end load funds outperform no-load funds?

Get a free copy of the Zacks research report on Tabula Rasa HealthCare (TRHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Increases Stock Position in Fidelity National Information Servcs Inc
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Increases Stock Position in Fidelity National Information Servcs Inc
Chevron Co.  Shares Acquired by Massachusetts Financial Services Co. MA
Chevron Co. Shares Acquired by Massachusetts Financial Services Co. MA
180 Shares in Alphabet Inc  Acquired by Groesbeck Investment Management Corp NJ
180 Shares in Alphabet Inc Acquired by Groesbeck Investment Management Corp NJ
MITSUBISHI ELEC/ADR  Stock Price Down 1.6%
MITSUBISHI ELEC/ADR Stock Price Down 1.6%
SG Americas Securities LLC Increases Position in Liberty Broadband Corp Series C
SG Americas Securities LLC Increases Position in Liberty Broadband Corp Series C
Belden Inc.  Shares Bought by SG Americas Securities LLC
Belden Inc. Shares Bought by SG Americas Securities LLC


 
© 2006-2019 Zolmax.